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1. Introduction 
The contraction-relaxation cycle of cardiac mus- 
cle, like that of skeletal muscle, is quantitatively con- 
trolled by the translocation of Ca2’ between intracel- 
lular structures [l-4]. However, unlike skeletal mus- 
cle, contraction of cardiac muscle is dependent on the 
concentration of extracellular Ca*+. Entry of a small 
amount of Ca2+ during the plateau phase of the ac- 
tion potential is thought to provide a trigger for the 
release of a larger amount of bound calcium from in- 
tracellular storage sites [5,6]. When the intracel- 
lular Ca2+ concentration rises above about lo-’ M, 
inhibition of actomyosin ATP-ase is relieved by Ca2+ 
binding to a subunit of troponin in the troponin- 
tropomyosin-actomyosin complex, and contrac- 
tion is initiated [4]. Relaxation occurs by an energy- 
dependent removal of Ca2+ from its troponin binding 
sites. Isolated sarcoplasmic reticulum vesicles and 
mitochondria are both able to accumulate Ca2+ against 
a concentration gradient by energy-linked processes 
[7,8] , and a question has arisen recently concerning 
their relative roles for Ca2+ sequestration in vivo [9- 
111. 
Experiments reported here were designed to eluci- 
date the role of mitochondria in the calcium cycle, 
using intact working rat heart preparation perfused 
with medium containing glucose. Data obtained with 
the rat heart are compared with similar studies using 
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frog hearts, since amphibian cardiac muscle is noted 
for its relative deficiency of sarcoplasmic reticulum 
[ 121. Use is made of the energy transfer inhibitor 
oligomycin, which prevents ATP-supported but not 
respiration-supported Ca2’ uptake by isolated mito- 
chondria [8]. Our conclusion is that mitochondria 
in the intact mammalian heart play only a minor 
role in the control of beat-to-beat calcium cycle, and 
appear not to be involved in producing an energy de- 
pendent decrease of intracellular Ca2’ during relaxa- 
tion. On the other hand, in frog cardiac muscle, 
mitochondrial Ca2+ sequestration and release is of 
importance in the contraction-relaxation cycle, 
and part of the mitochondrial respiration is Ca2+- 
linked. 
2. Methods 
Hearts from well fed male rats (220-250 g) of 
the Wistar strain were perfused at 35” in a modified 
version of the working heart apparatus described by 
Neely et al. [ 131. The basic modification consisted 
in having a constantly filled 20 ml reservoir, fitted 
with an overflow, 80 cm above the aortic cannula. 
This ensured a constant perfusion of the coronary 
circulation when the aortic pressure failed to rise 
above the pressure head during systole. Left ventri- 
cular filling occurred via the cannulated pulmonary 
vein from a small reservoir placed about 10 cm above 
the heart. The perfusion fluid was modified Krebs- 
Henseleit buffer containing 118 mM NaCl, 25 mM 
NaHCOs ,4.7 mM KCl, 1.2 mM KHZ PO4, 1.2 mM 
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MgS04 and variable amounts of CaCls , which was 
equilibrated with Oa or Na gas containing 5% CO2 . 
Left ventricular pressure was measured with a 
Statham P23d pressure transducer by inserting a 22 
gauge needle through the ventricle wall. Aortic pres- 
sure was measured directly by means of a similar 
transducer. Pressure changes were recorded on a Brush 
440 recorder. Cardiac output was estimated from the 
sum of the left ventricular output and the coronary 
flow rate. Pressure work was calculated according to 
Neely et al. [ 13 ] . Oxygen consumption was calculated 
from the coronary flow rate measured at 2 min inter- 
vals and the A-V oxygen tension difference. The 
oxygen tension of the coronary effluent was measured 
continuously by means of a Clark oxygen electrode. 
Frog hearts were perfused with Ringer’s fluid 
through the aorta using air saturated medium and a 
pressure head of 25 cm. Ventricular pressure was 
measured as for rat hearts. 
3. Results 
Both heart work and oxygen consumption are critic- 
ally dependent on the Ca’+ concentration of the per- 
fusion medium. Fig. 1 illustrates the rapidity of the 
response to a stepwise increase of Ca’+ from 0.5 to 
1.5 mM in a rat heart paced at 240 beats/min and per- 
fused with 20 mM glucose. Oxygen uptake increased 
within 2 min from 3.4 to 4.8 matoms/g dry wt/hr, 
while pressure work doubled from a value of 0.14 
kg-m/g dry wt/min. Although the left ventricular pres- 
sure change was small, the work of the heart doubled 
and was accounted for mainly by an increased stroke 
volume. 
Addition of oligomycin (6 pg/ml) to a rat heart 
paced at 240 beats/min and perfused with 20 mM 
glucose and 0.5 mM Ca”* produced a gradual fall of 
oxygen uptake from 3 to 1.3 matoms/g dry wt/hr and 
a 65% decrease of left ventricular pressure over a 20 
min interval (fig. 2). Further additions of oligomycin 
caused no additional effects indicating that respira- 
tion was maximally inhibited. Subsequent increase 
of the external Ca’+ to 1.5 mM produced a marked 
increase of left ventricular pressure, but oxygen up- 
take remained unaffected. Confirmatory evidence that 
flux through the mitochondrial electron transport 
chain was not changed upon Ca’+ addition was also 
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Fig. 1. Effect of Ca’* addition on oxygen consumption, left 
ventricular pressure and work in the perfused rat heart. The 
solid area of the pressure trace represents the maximum sys- 
tolic-diastolic excursion. 
provided by surface fluorometry measurements. No 
effect was observed on the oxidation-reduction state 
of either the flavin or pyridine nucleotides after Ca2+ 
addition in the presence of oligomycin. 
In a similar experiment, but with the heart perfused 
initially with 1.5 mM Ca’+, oligomycin decreased 
oxygen uptake from 5 to 1.4 matoms/g dry wt/hr 
(fig. 3). Left ventricular pressure fell to 30% of its 
initial value, and the heart ceased pumping fluid 
against the aortic pressure head. Addition of 0.1 pg/ 
ml of norepinephrine doubled the left ventricular 
pressure, but again no effect on oxygen uptake was 
seen, A similar response to norepinephrine in the 
presence of oligomycin was observed at a perfusate 
Ca2’ concentration of 0.5 mM. 
These data illustrate two points. First, the large 
decrease of oxygen uptake obtained upon inhibiting 
mitochondrial ATP production with oligomycin 
shows that in the working rat heart more than 70% 
of the respiration must be ADP-linked. The low rates 
of respiration observed here with oligomycin-inhibited 
hearts are similar to those reported by Challoner [ 14, 
151 for Langendorff-perfused rat hearts after oligo- 
mycin addition or K+ arrest. Thus, the residual, oligo- 
mycin-insensitive respiration appears unrelated to 
the mechanical activity of the heart. The low phos- 
phate potential induced by oligomycin [ 141 causes 
a stimulation of phosphofructokinase. Enhanced 
ATP production by glycolysis is able to support cardiac 
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Fig. 3. Effect of norepinephrine addition on oxygen consumption and left ventricular pressure in rat hearts perfused in the pres- 
ence of oligomycin with 1.5 mM Ca’+. 
contractile activity, although with diminished perfor- 
mance. Secondly, the lack of effect of an increased 
availability of Ca2+ to the actomyosin complex on 
respiratory activity indicates that mitochondria in the 
rat heart are not involved in the energy-linked Ca2+ 
uptake required for relaxation. 
Further support for this conclusion was provided 
by the experiments shown in fig. 4 in which rat hearts 
were perfused under anaerobic conditions in the pres- 
ence of 20 mM glucose. Intraventricular pressure deve- 
lopment was well maintained when the mechanical 
activity was supported by ATP produced from glycol- 
ysis, although the heart rate fell to 60-80 beats/min. 
Addition of oligomycin to prevent any ATP-supported 
Ca2+ uptake by mitochondria caused only a transient 
decrease of left ventricular pressure, and contractility 
recovered after a few minutes. Left ventricular pres- 
sure development was increased either by raising the 
external Ca2+ concentration from 0.5 to 1.5 mM 
(fig. 4A) or by the addition of norepinephrine (fig. 
4B). Perfusion of the hearts beyond the times shown 
on the traces gave no evidence that the ability of the 
heart to relax was impaired. These data indicate that 
non-mitochondrial Ca’+-sequestering systems (presum- 
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Fig. 5. Effect of Ca’+ addition on ventricular pressure in frog hearts perfused aerobically in: A) the absence, and B) the presence 
of oligomycin. Trace C) shows the effect of Ca*+ addition in anaerobic frog hearts perfused in the presence of oligomycm. 
ably sarcoplasmic reticulum) are sufficiently active to 
support complete relaxation when the heart is stressed 
under conditions in which possible Ca’+ uptake by 
mitochondria is prevented. 
In contrast to the above studies with the rat heart, 
similar experiments with perfused frog hearts gave 
markedly different results. Figs. 5A and SB show the 
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effect of oligomycin on the response of the aerobic, 
glucose perfused frog heart to an increase of per- 
fusate Ca2+ from 0.15 to 1.15 mM. With frog heart, 
unlike rat heart, addition of Ca2+ in the presence of 
5 pg/ml oligomycin not only augmented contract- 
ility but also more than doubled the rate of oxygen 
uptake, indicating a direct involvement of mito- 
chondria in the energy-linked removal of Ca2’ from 
troponin during relaxation. Fig. 5C shows that 
ventricular pressure development by the frog heart 
was essentially suppressed when the heart perfused 
initially with 0.25 mM Ca2+ was subjected first to 
oligomycin and then to anoxia in order to prevent 
both ATP-linked and respiratory-linked Ca2+ uptake 
by the mitochondria. However, subsequent Ca2’ ad- 
dition to 1.25 mM enhanced contractility with no 
development of contracture, indicating that Ca2’ 
sequestering systems other than mitochondria are 
also involved in the calcium cycle of frog heart. 
4. Discussion 
Previous studies by Horn et al. [ 161 using rat hearts 
perfused with 1 mM iodoacetate, 5 mM pyruvate and 
1 pg/ml oligomycin showed that upon subsequent 
epinephrine addition or electrical stimulation, con- 
traction of the muscle developed. These results were 
interpreted on the basis of a failure of mitochondria 
to support Ca2+ uptake. Since in our experiments rat 
hearts perfused anaerobically in the presence of oligo- 
mycin showed no impairment of relaxation, the data 
of Horn et al. [ 161 may be interpreted on the basis of 
a non-specific toxic action of iodoacetate or as a con- 
sequence of ATP deficiency. Other evidence in favor 
of mitochondria being involved in Ca2+ uptake during 
muscular relaxation in uivo is also very tenuous, being 
based on the distribution of 45 Ca2+ between mito- 
chondria and sarcoplasmic reticulum vesicles isolated 
from cardiac or skeletal muscle after injection of 
45 Ca2+ to the whole animal [9, lo] or to the perfused 
rat heart [ 1 l] . Although mitochondria contained the 
bulk of the 45 Ca2+ found in the homogenate, it is 
probable that this can be accounted for by the iso- 
tope becoming bound to the mitochondrial mem- 
branes during fractionation, followed by release of 
4s Ca2+ upon discruption of the sarcoplasmic reticulum 
tubules and other membranes. Three other points 
based on experiments with isolated mammalian mito- 
chondria argue against their having more than a minor 
role for Ca2+ uptake during muscle relaxation: i) the 
rate of Ca2+ uptake is too slow at Ca2+ concentrations 
between lo-’ and 10e7 M [17,18] ; ii) the affinity 
of mitochondria for active Ca2+ uptake is much lower 
than that for sarcoplasmic reticulum [7,19] ; and iii) 
the only known mechanisms for discharging Ca2+ from 
the mitochondria provide for a relatively slow Ca2+ 
release and are associated with complete energy deple- 
tion [S, 171 ; an event unlikely to occur in u&o. Non- 
energy-linked binding of Ca2+ to mitochondria during 
relaxation also appears unlikely because of the relativ- 
ely low affinity of the bulk of the cation binding sites 
for Ca2+ (10m4 M) and the small number of high af- 
finity (10e6 M) Ca2+ binding sites [8,20] . 
It is of particular interest that in frog hearts, which 
are characterized by an almost nonexistent sarcoplas- 
mic reticulum, the mitochondria are shown to be in- 
volved in an energy-dependent Ca2+ uptake during 
the contraction-relaxation cycle. These data con- 
trast with results obtained with the rat heart, and 
suggest he possibility that amphibian cardiac mito- 
chondria may have a higher affinity for Ca2+ than 
mammalian mitochondria in order to effect a release 
of Ca2+ from the troponin binding sites. Since evidence 
is at hand that Ca2+ release occurs with frog cardiac 
mitochondria in vivo, studies with these mitochondria 
may provide a more suitable preparation than mamma- 
lian mitochondria for elucidation of the physiological 
mechanism of Ca2+ release. Our data suggest hat 
significant differences may exist between the two 
types of mitochondria in relation to the physiological 
mechanisms of Ca2+ uptake and release. 
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